基于“一气周流”探讨肠道菌群与H型高血压的关系
Discussion on the Relationship between Gut Microbiota and H-Type Hypertension Based on “One Qi Circulation” Theory
DOI: 10.12677/acm.2025.15113152, PDF,   
作者: 王晓敏：黑龙江中医药大学研究生院，黑龙江 哈尔滨；王 岩*：黑龙江中医药大学附属第一医院中医经典病房，黑龙江 哈尔滨
关键词: H型高血压；“一气周流”理论；肠道菌群；H-Type Hypertension； “One Qi Circulation” Theory； Gut Microbiota
摘要: H型高血压发病率居高不下，肠道菌群可通过多途径参与血压调节，有望成为H型高血压治疗的新靶点。“一气周流”理论强调脾胃为人体气机枢纽，其化生之中气既是疾病发生的关键环节，也是康复治疗的重要基础。本文系统阐释肠道微生态紊乱作用于H型高血压的具体机制，提出在“一气周流”理论指导下，调理脾胃以调节肠道菌群，达到治疗H型高血压的目的。
Abstract: The incidence of H-type hypertension remains high. The gut microbiota can participate in blood pressure regulation through multiple pathways and is expected to become a new target for the treatment of H-type hypertension. The “One Qi Circulation” Theory emphasizes that the spleen and stomach are the key to the body’s qi movement, and the zhong qi they generate is not only a crucial link in the occurrence of diseases but also an important foundation for rehabilitation treatment. This article systematically explains the specific mechanism by which intestinal microecological disorders affect H-type hypertension and proposes that under the guidance of the “One Qi Circulation” Theory, regulating the spleen and stomach to adjust the gut microbiota can achieve the purpose of treating H-type hypertension.
文章引用：王晓敏, 王岩. 基于“一气周流”探讨肠道菌群与H型高血压的关系[J]. 临床医学进展, 2025, 15(11): 725-731. https://doi.org/10.12677/acm.2025.15113152

参考文献

[1] 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
[2] 李建平, 卢新政, 霍勇, 等. H型高血压诊断与治疗专家共识[J]. 中国医学前沿杂志, 2016, 8(5): 23-28+6.
[3] Qian, X.L., Cao, H., Zhang, J., Gu, Z., Tang, W., Shen, L., et al. (2021) The Prevalence, Relative Risk Factors and MTHFR C677T Genotype of H Type Hypertension of the Elderly Hypertensives in Shanghai, China: A Cross-Section Study: Prevalence of H Type hypertension. BMC Cardiovascular Disorders, 21, Article No. 376. [Google Scholar] [CrossRef] [PubMed]
[4] Xiao, K., Xv, Z., Xv, Y., Wang, J., Xiao, L., Kang, Z., et al. (2023) H-Type Hypertension Is a Risk Factor for Chronic Total Coronary Artery Occlusion: A Cross-Sectional Study from Southwest China. BMC Cardiovascular Disorders, 23, Article No. 301. [Google Scholar] [CrossRef] [PubMed]
[5] 付帝钧, 郑彩平, 张鑫, 等. 中老年H型高血压病中医证候特征及中医辨证治疗的研究进展[J]. 时珍国医国药, 2021, 32(3): 703-707.
[6] 黄元御. 四圣心源[Ｍ]. 孙洽熙, 校. 北京: 中国中医药出版社, 2009.
[7] 黄艺霖, 李爽, 贺正庸, 等. 肠道菌群在高血压治疗中的研究进展[J]. 实用医学杂志, 2025, 41(19): 3129-3134.
[8] 周彬, 何燕, 柳陈坚, 等. 肠道微生物群调节血压的研究进展[J]. 微生物学报, 2025, 65(8): 3492-3506.
[9] 孙鹏伟, 皇甫卫忠. 肠道菌群与高血压关系的研究进展[J]. 疑难病杂志, 2024, 23(6): 751-755+768.
[10] 孔娟. 高同型半胱氨酸血症诊疗专家共识[J]. 肿瘤代谢与营养电子杂志, 2020, 7(3): 283-288.
[11] 郝轩, 张军茹. 基于肠道菌群对中医药防治H型高血压的理论探讨[J]. 现代中医药, 2022, 42(5): 81-88.
[12] 宋春颖, 曹煜. 益生菌辅助治疗对H型高血压患者临床指标改善及肠道微生态的影响分析[J]. 中国病原生物学杂志, 2025, 20(4): 428-433.
[13] Lee, D.H., Kim, M.T. and Han, J.H. (2024) GPR41 and GPR43: From Development to Metabolic Regulation. Biomedicine & Pharmacotherapy, 175, Article 116735. [Google Scholar] [CrossRef] [PubMed]
[14] Kaye, D.M., Shihata, W.A., Jama, H.A., Tsyganov, K., Ziemann, M., Kiriazis, H., et al. (2020) Deficiency of Prebiotic Fiber and Insufficient Signaling through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease. Circulation, 141, 1393-1403. [Google Scholar] [CrossRef] [PubMed]
[15] Wu, J., Zhao, J., Cheng, Y., Zhou, H., Shen, G., Ding, H., et al. (2025) The Differences in Intestinal Flora and Metabolites between H-Type Hypertension and Non-H-Type Hypertension. Journal of Translational Medicine, 23, Article No. 329. [Google Scholar] [CrossRef] [PubMed]
[16] Li, J., Yang, X., Zhou, X. and Cai, J. (2021) The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxidants & Redox Signaling, 34, 811-830. [Google Scholar] [CrossRef] [PubMed]
[17] Jiang, S., Shui, Y., Cui, Y., Tang, C., Wang, X., Qiu, X., et al. (2021) Gut Microbiota Dependent Trimethylamine N-Oxide Aggravates Angiotensin II-Induced Hypertension. Redox Biology, 46, Article 102115. [Google Scholar] [CrossRef] [PubMed]
[18] Liu, M., Han, Q. and Yang, J. (2018) Trimethylamine-N-Oxide (TMAO) Increased Aquaporin-2 Expression in Spontaneously Hypertensive Rats. Clinical and Experimental Hypertension, 41, 312-322. [Google Scholar] [CrossRef] [PubMed]
[19] Takeuchi, O. and Akira, S. (2010) Pattern Recognition Receptors and Inflammation. Cell, 140, 805-820. [Google Scholar] [CrossRef] [PubMed]
[20] Griendling, K.K., Camargo, L.L., Rios, F.J., Alves-Lopes, R., Montezano, A.C. and Touyz, R.M. (2021) Oxidative Stress and Hypertension. Circulation Research, 128, 993-1020. [Google Scholar] [CrossRef] [PubMed]
[21] Schiffrin, E.L. (2012) Vascular Remodeling in Hypertension: Mechanisms and Treatment. Hypertension, 59, 367-374. [Google Scholar] [CrossRef] [PubMed]
[22] 张翌晨, 格桑德吉, 郑林曦, 等. Bifidobacterium animalis subsp. lactis (BPL1)干预对原发性高血压大鼠的血压调节及其机制研究[J]. 营养学报, 2024, 46(6): 574-582.
[23] 王淑荣, 杨娜, 苑宁, 等. H型高血压中医证型分布频率的Meta分析[J]. 中医临床研究, 2023, 15(30): 61-67.
[24] 吕娟, 刘玲, 张婷, 等. 高同型半胱氨酸血症与原发性高血压中医证型关联分析[J]. 社区医学杂志, 2020, 18(23): 1604-1607.
[25] 么燕雪, 张新元. H型高血压中医证型分布特征及其与靶器官损害的相关性研究进展[J]. 中西医结合心脑血管病杂志, 2023, 21(11): 2016-2020.
[26] 李成, 段锦龙, 张津菊, 等. 论《脾胃论》升降理论在心系疾病中的应用[J]. 中华中医药杂志, 2021, 36(7): 3912-3915.
[27] 邵铁娟, 李海昌, 谢志军, 等. 基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J]. 中华中医药杂志, 2014, 29(12): 3762-3765.
[28] 戴思思, 卢圣花, 何涛, 等. 程丑夫从气机升降论治高血压病经验[J]. 中医杂志, 2023, 64(7): 667-670+676.
[29] 蔡昀潞, 王建波, 曲怡, 等. 基于“肠道菌群-免疫反应”探讨针灸从脾治疗高血压病的作用机制[J]. 实用中医内科杂志, 2021, 35(2): 84-87.
[30] 石若玉, 李东东. 基于数据挖掘探讨中医药治疗H型高血压病的用药规律[J]. 中国中药杂志, 2024, 49(9): 2522-2531.
[31] Li, X., Zhang, X., Yang, W., Guo, L., Huang, L., Li, X., et al. (2021) Preparation and Characterization of Native and Autoclaving-Cooling Treated Pinellia Ternate Starch and Its Impact on Gut Microbiota. International Journal of Biological Macromolecules, 182, 1351-1361. [Google Scholar] [CrossRef] [PubMed]
[32] Gao, K.X., Peng, X., Wang, J., Wang, Y., Pei, K., Meng, X., et al. (2024) In Vivo Absorption, in Vitro Simulated Digestion and Fecal Fermentation Properties of Polysaccharides from Pinelliae Rhizoma Praeparatum Cum Alumine and Their Effects on Human Gut Microbiota. International Journal of Biological Macromolecules, 266, Article 131391. [Google Scholar] [CrossRef] [PubMed]
[33] 华中一, 李洪梅, 孙建辉, 等. 鲜天麻提取物对小鼠肠道菌群结构的影响[J]. 中国中药杂志, 2019, 44(5): 1004-1009.
[34] Li, N., Wang, D., Wen, X., Chu, R., Fan, J., Chen, Y., et al. (2023) Effects of Polysaccharides from Gastrodia elata on the Immunomodulatory Activity and Gut Microbiota Regulation in Cyclophosphamide-Treated Mice. Journal of the Science of Food and Agriculture, 103, 3390-3401. [Google Scholar] [CrossRef] [PubMed]
[35] Chen, L., Chang, X., Wu, C., Luo, G., Zhang, P. and Tian, W. (2024) Polysaccharide Extracted from Atractylodes macrocephala Improves the Spleen Deficiency Constipation in Mice by Regulating the Gut Microbiota to Affect the 5-HT Synthesis. Neurogastroenterology & Motility, 36, e14875. [Google Scholar] [CrossRef] [PubMed]
[36] 冯敏, 孙凡中, 万鸣, 等. 茯苓对小鼠肠道菌群的影响[J]. 食品研究与开发, 2025, 46(11): 30-36.
[37] 程诗雨, 陈晓云, 谭奚扬, 等. 橘红提取物对非酒精性脂肪肝合并肥胖肠道菌群及中医体质影响的随机对照研究[J]. 中国中西医结合杂志, 2024, 44(10): 1206-1214.
[38] 吴宏华, 周先富. H型高血压患者采用半夏白术天麻汤加减综合治疗对改善血压及血浆Hcy的影响[J]. 中华中医药学刊, 2016, 34(9): 2295-2297.
[39] 吴赛, 于广宇, 胡心荷, 等. 加味半夏白术天麻汤对代谢性高血压大鼠的有益作用及机制研究[J]. 中国病原生物学杂志, 2024, 19(2): 149-156.

为你推荐